Andrew Hessel

Andrew Hessel is a micro-biologist and geneticist and entrepreur. He founded the Pink Army Cooperative, and Humane Genomics, Inc.[1][2] Between 2012-2017, he was a Distinguished Researcher at Autodesk Life Sciences.[3][4] Hessel is co-chair of Bioinformatics and Biotechnology at Singularity University, and a fellow at the Institute for Science, Society, and Policy at the University of Ottawa.[5] In 2002, he co-founded Miikana Therapeutics, a clinical-stage drug development company. The company was acquired by Entremed in 2006 for $39M in cash and milestones.[6][7] He received a M.Sc. in biology from University of Calgary 1993-1995 and was Research Operations Manager at Amgen Institute 1995-2002.[6] He has also been involved in Genome Project-Write since the start in 2016 and is currently Chairman of the Board and Co-Executive Director.[4][8][9]

Hessel at the Humanity+ in 2010

References
  1. "Andrew Hessel bio from his own website". Retrieved Sep 20, 2020.
  2. "Andrew Hessel bio at bioinnovate.co". Archived from the original on 2018-03-27. Retrieved 2018-03-27.
  3. "Andrew Hessel bio at AutoDesk Research". Archived from the original on 2018-03-27. Retrieved 2018-03-27.
  4. Steven Kotler (Feb 1, 2018). "The Human Operating System Gets an Overhaul". Neo.life (Medium).
  5. "Faculty - Andrew Hessel". Singularity University. Retrieved Sep 20, 2020.
  6. "Andrew Hessel LinkedIn". Retrieved Sep 20, 2020.
  7. "Hessel Bio pdf" (PDF). Retrieved Sep 20, 2020.
  8. "Genome Project-Write". Retrieved Sep 20, 2020.
  9. Boeke, JD, Church G, Hessel A, Kelley NJ, Arkin A, Cai Y, Carlson R, Chakravarti A, Cornish VW, Holt L, Isaacs FJ, Kuiken T, Lajoie M, Lessor T, Lunshof J, Maurano MT, Mitchell LA, Rine J, Rosser S, Sanjana NE, Silver PA, Valle D, Wang H, Way JC, Yang L; et al. (2 June 2016). "The Genome Project–Write". Science. 353 (6295): 126–127. doi:10.1126/science.aaf6850. PMID 27256881.CS1 maint: multiple names: authors list (link)
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.